Indicators of vaccination status in patients with chronic kidney disease: the importance of recommendations from healthcare providers.

Publication date: Jul 01, 2025

Influenza and pneumococcal vaccinations are strongly encouraged for individuals with chronic kidney disease (CKD); however, vaccination rates remain below the target. Establishing factors influencing vaccination status may guide approaches to enhance vaccine uptake among this vulnerable patient population. A cross-sectional study involved 307 patients diagnosed with CKD for at least one year (40. 4% non-dialysis, 37. 1% dialysis, and 22. 5% kidney transplantation). Demographic data, clinical conditions, and social factors, such as nutritional status, frailty, and health literacy, were evaluated. The vaccination rates for influenza, and pneumococcus, along with the associated variables, have been analyzed. The average age of the patients was 57 years (+/- 16), with a predominance of males (56. 7%). The percentages of individuals unvaccinated for influenza, pneumococcus, and SARS-CoV-2 were 61. 9%, 60. 9%, and 5. 9%, respectively, while only 11 patients (3. 9%) received an annual influenza vaccine. Healthcare providers recommended influenza and pneumococcal vaccination to 60. 3% and 37. 1% of patients, 71% of whom visited a physician 5 or more times a year, respectively. The frequency of regular or infrequent influenza vaccination was significantly correlated with healthcare providers’ recommendations (HR, 14. 348; 95% CI, 6. 842-30. 086; p 

Open Access PDF

Concepts Keywords
Annual Adult
Frailty Aged
Influenza Chronic kidney disease
Kidney COVID-19
Vaccinations COVID-19 Vaccines
COVID-19 Vaccines
Cross-Sectional Studies
Female
Health Personnel
Humans
Infectious disease
Influenza
Influenza Vaccines
Influenza Vaccines
Influenza, Human
Male
Middle Aged
Pneumococcal Vaccines
Pneumococcal Vaccines
Pneumococcus
Renal Insufficiency, Chronic
Vaccination
Vaccination
Vaccination Coverage

Semantics

Type Source Name
disease MESH chronic kidney disease
disease MESH Influenza
disease MESH nutritional status
disease MESH frailty
pathway REACTOME Reproduction
drug DRUGBANK Coenzyme M
disease MESH COVID-19
disease MESH Infectious disease
pathway REACTOME Infectious disease

Original Article

(Visited 1 times, 1 visits today)